Celgene Corporation

CELG 
(NASDAQ) 
 
$ 88.65
Updated 09:06:33
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 8,493,239
High $ 90.43
Low $ 88.15
Open $ 90.07
ISIN
Prev close $ 90.40
# of shares 701.02M
Market cap 62,146M USD
Intraday

Market closed
Celgene Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  88.65 -2.2% Stock price decreasing 3.1% Stock price increasing 31.3% Stock price increasing -2.2% Stock price decreasing -5.5% Stock price decreasing
Powered by TradingView

News about Celgene Corporation

  • English
  • Regulatory news
04 Jan
 
10 Dec
 
31 Oct
 
27 Sep
 
14 Jun
 
29 May
 
25 May
 
23 May
 
22 May
 
22 May
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Bristol-Myers Squibb Company 50,13 -3.0% Stock price decreasing 0.8% Stock price increasing -5.8% Stock price decreasing -17.2% Stock price decreasing -24.0% Stock price decreasing -3.6% Stock price decreasing
 
Johnson & Johnson 135,42 -0.7% Stock price decreasing 5.1% Stock price increasing -4.6% Stock price decreasing 0.6% Stock price increasing 4.2% Stock price increasing 4.9% Stock price increasing
 
Merck & Company Inc (new) 79.83 0.0% Stock price increasing 5.3% Stock price increasing 6.7% Stock price increasing 15.6% Stock price increasing 46.3% Stock price increasing 4.5% Stock price increasing
 
Pfizer Inc 42,14 -0.6% Stock price decreasing -0.3% Stock price decreasing -2.2% Stock price decreasing 0.2% Stock price increasing 17.9% Stock price increasing -3.5% Stock price decreasing
 
Amgen Inc 185,50 -1.5% Stock price decreasing -8.2% Stock price decreasing -3.8% Stock price decreasing -6.2% Stock price decreasing 1.7% Stock price increasing -4.7% Stock price decreasing
 
Gilead Sciences Inc 65.55 -3.0% Stock price decreasing -4.4% Stock price decreasing -1.8% Stock price decreasing -11.2% Stock price decreasing -17.4% Stock price decreasing 4.8% Stock price increasing
 
Vertex Pharmaceuticals Incorpo.. 183.06 -2.7% Stock price decreasing -5.6% Stock price decreasing 14.2% Stock price increasing 3.0% Stock price increasing 16.2% Stock price increasing 10.5% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 6,111.00 -2.1% Stock price decreasing 10.0% Stock price increasing 0.4% Stock price increasing 2.9% Stock price increasing 28.1% Stock price increasing 4.1% Stock price increasing
 
Novartis AG 90.51 0.7% Stock price increasing 2.5% Stock price increasing 1.7% Stock price increasing 8.1% Stock price increasing 6.2% Stock price increasing 5.5% Stock price increasing
 
Takeda PHARM.CO.LTD. 34.73 -2.5% Stock price decreasing -1.4% Stock price decreasing 5.2% Stock price increasing -4.2% Stock price decreasing -21.3% Stock price decreasing 20.0% Stock price increasing
 
Biogen Inc 321,17 -3.5% Stock price decreasing -5.2% Stock price decreasing 1.8% Stock price increasing -6.9% Stock price decreasing 12.8% Stock price increasing 6.7% Stock price increasing
 
Roche Hldg Sp.Adr 1/8 29.27 -1.6% Stock price decreasing 3.7% Stock price increasing 9.1% Stock price increasing 11.7% Stock price increasing 22.6% Stock price increasing 13.3% Stock price increasing

Company profile

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Peers

Instruments Last Change  
Bristol-Myer.. 50,13 -2.3% Stock price decreasing
Johnson & Jo.. 135,42 -0.7% Stock price decreasing
Merck & Comp.. 79.83 0.5% Stock price increasing
Pfizer Inc 42,14 -0.1% Stock price decreasing
Amgen Inc 185,50 0.0% Stock price unchanged
Gilead Scien.. 65.55 0.0% Stock price unchanged
Vertex Pharm.. 183.06 0.0% Stock price unchanged
Astrazeneca .. 6,111.00 0.2% Stock price increasing
Novartis AG 90.51 -0.3% Stock price decreasing
Takeda PHARM.. 34.73 -0.9% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Biogen Inc 321,17 0.0% Stock price unchanged
Roche Hldg S.. 29.27 0.9% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 February 2019 09:22:06
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB1 - 2019-02-22 10:22:06 - 2019-02-22 09:22:06 - 1000 - Website: OKAY